Government-backed pilots investigate how tech can better secure the drug supply chain
The FDA is looking to form a tighter grip on security for the wider drug supply chain and shared the first results from a pilot program aimed at accomplishing that goal.
The Drug Supply Chain Security Act (DSCSA), enacted in 2013, directed the FDA to explore methods to boost the safety and security of the drug supply chain. In 2019, the FDA set up pilot programs to help the agency and other players in the supply chain understand more technical aspects of the supply chain and assist with finding areas of security improvement. Around 20 groups signed on to the pilot program, including Sanofi and AmerisourceBergen, in addition to some health tech companies and academic centers.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.